IRulya Therapeutics
IRLA----
IRulya Therapeutics (IRLA)
IRulya Therapeutics Inc., a biotechnology company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare di...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
- 52wk Low
- --
- Float Mkt Cap
- --
- Market Cap
- --
- P/ETTM
- --
- P/EDynamic
- --
- P/EStatic
- --
- EPSTTM
- --
- EPSDynamic
- --
- EPSStatic
- --
- BVPS
- --
- P/B
- --
- Circulating Supply
- --
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- --
- Min lot size
- --
- Currency
- --
IRulya Therapeutics Analyst Rating
View moreForecast & Rating
Oct 9, 2026Price forecast
$75.00134.16%
Forecast & RatingStrong buy
9analysts
- Strong buy66.67%
- Buy22.22%
- Hold11.11%
- Sell0.00%
- Strong sell0.00%